...
首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix.
【24h】

Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix.

机译:在细胞外基质的情况下,通过细胞因子调节人甲状腺细胞在恶性和非恶性人类白细胞抗原和细胞内粘附分子-1表面表达的表达。

获取原文
获取原文并翻译 | 示例

摘要

Interactions between malignant cells and their environment are achieved via cell-surface receptors and adhesion molecules. The extracellular matrix (ECM) and ECM-bound cytokines modulate the expression of cell-surface molecules on target malignant cells, which may lead to changes in their susceptibility to cytolysis, in their ability to present antigens, and in the induction of local immune-cell activation and patrol. Eventually, these alterations may culminate in either the destruction, or escape and proliferation, of the tumor. We studied the effects of the ECM and its components in a "naive" form or following binding of the inflammatory cytokines interferon gamma (IFNgamma) and tumor necrosis factor alpha (TNFalpha) on the surface expression of human leukocyte antigen (HLA) class-I, HLA class-II (HLA-DR), and intracellular adhesion molecule-1 (ICAM-1), on nonmalignant and malignant thyroid cells. The basal expression of HLA class-I molecules was not significantly changed either by naive ECM and its components or by ECM-bound cytokines. ECM synergized with IFNgamma and TNFalpha in inducing HLA-DR molecules on nonmalignant and malignant thyrocytes, with higher HLA-DR levels on the malignant cells. The laminin component, in particular, synergized with IFNgamma. Basal ICAM-1 expression on nonneoplastic cells was not significantly affected by the cytokines when grown in the absence of ECM, but was significantly upregulated when cells were cultured on ECM. In contrast, in malignant thyrocyte cultures, ECM significantly attenuated IFNgamma- and TNFalpha-mediated enhancement of ICAM-1 expression. We concluded that signals derived from ECM-embedded cytokines participate in the regulation of key thyroid cell surface molecules and, thus, may affect the final outcome of human thyroid malignancies.
机译:恶性细胞与其环境之间的相互作用是通过细胞表面受体和粘附分子来实现的。细胞外基质(ECM)和ECM结合的细胞因子调节靶恶性细胞上细胞表面分子的表达,这可能导致其对细胞溶解的敏感性,呈递抗原的能力以及诱导局部免疫反应的能力发生变化。细胞活化和巡逻。最终,这些改变可能最终导致肿瘤的破坏,逃逸和扩散。我们研究了“天真”形式或在炎症性细胞因子干扰素γ(IFNgamma)和肿瘤坏死因子α(TNFalpha)结合后ECM及其组分对人白细胞抗原(HLA)I类表面表达的影响,HLA II类(HLA-DR)和细胞内粘附分子1(ICAM-1),用于治疗非恶性和恶性甲状腺细胞。幼稚的ECM及其成分或结合ECM的细胞因子均未显着改变HLA I类分子的基础表达。 ECM与IFNgamma和TNFalpha协同作用,诱导非恶性和恶性甲状腺细胞上的HLA-DR分子,在恶性细胞上具有更高的HLA-DR水平。层粘连蛋白组分尤其与IFNγ协同作用。在无ECM的情况下生长时,非肿瘤细胞上的基础ICAM-1表达不受细胞因子的显着影响,但在ECM上培养细胞时,ICAM-1的表达显着上调。相反,在恶性甲状腺细胞培养物中,ECM显着减弱了IFNgamma和TNFalpha介导的ICAM-1表达的增强。我们得出的结论是,源自ECM嵌入的细胞因子的信号参与了关键甲状腺细胞表面分子的调节,因此可能会影响人类甲状腺恶性肿瘤的最终结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号